CACNA1H and glioblastoma: Compared to commonly used established cell lines and the normal brain, Cav3.2 expression is elevated in human glioblastoma and in glioblastoma stem cells that are resistant to radio and chemotherapy, and its deregulation correlates with worsened patient survival.